Background In patients with suspected coronary heart disease, single-photon emission computed tomog raphy (SPECT) is the most widely used test for the assessment of myocardial ischaemia, but its diagnostic accuracy is reported to be variable and it exposes patients to ionising radiation. The aim of this study was to establish the diagnostic accuracy of a multi parametric cardiovascular magnetic resonance (CMR) protocol with x-ray coronary angiography as the reference standard, and to compare CMR with SPECT, in patients with suspected coronary heart disease.
Introduction
Coronary heart disease is a leading cause of death and disability.
1 Various techniques are used to diagnose coronary heart disease and assess the need for revascularisation. Increasingly, imaging tests have replaced exercise treadmill testing, with single-photon emission computed tomography (SPECT) being the most common. However, although a negative SPECT result provides reassuring prognostic information, it exposes patients to ionising radiation, and estimates of its accuracy vary widely. [2] [3] [4] Cardiovascular magnetic resonance (CMR) imaging could be an alternative to SPECT. Theoretical advantages of CMR include the lack of ionising radiation, high spatial resolution, and its multiparametric nature-ie, its ability to assess multiple aspects of pathology in a single examination (eg, ventricular function, myocardial perfusion, viability, and coronary artery anatomy). [5] [6] [7] [8] [9] [10] Small single 7, [11] [12] [13] [14] [15] and multi centre 16, 17 studies have tested the accuracy of stress-perfusion CMR alone for the detection of coronary heart disease and some studies showed equal 12 or improved 15 results compared with SPECT. Stressperfusion CMR and SPECT performed equally well in a subanalysis of a multicentre study (MR-IMPACT). 18 However, this study was underpowered and the population was highly selected (the entry criteria were previous coronary angiography or a positive SPECT). Evidence from large, prospective studies comparing the two techniques is lacking. Additionally, multiparametric CMR protocols might increase the diagnostic yield compared with stress perfusion alone, 9 but no large studies have investigated their clinical role. The inclusion of coronary MR angiography is especially relevant, because this component is time-consuming and the image quality is more variable than that of other CMR methods.
The Clinical Evaluation of MAgnetic Resonance imaging in Coronary heart disease (CE-MARC) study was designed to establish the diagnostic accuracy of multiparametric CMR in a large real world population, and to test the hypothesis that CMR yields higher diagnostic performance than SPECT, using X-ray angiography as the reference standard.
Methods

Patients and study design
The methods used in CE-MARC have been published previously. 19 Patients were recruited between March, 2006, and August, 2009, from two hospitals (Pinderfi elds General Hospital and Leeds Teaching Hospitals NHS Trust, UK). Consecutive patients with suspected angina pectoris were screened and enrolled if they had at least one major cardiovascular risk factor and a cardiologist judged them to have stable angina needing investigation, in accordance with contemporary clinical practice. Exclusion criteria 19 were previous coronary artery bypass surgery; crescendo angina or acute coronary syndrome; contraindication to CMR (eg, pacemaker) or adenosine infusion (eg, reversible airways disease, atrioventricular block); pregnancy; inability to lie supine; and a glomerular fi ltration rate of 30 ml/min per 1·73m² or less. The estimated prevalence of clinically signifi cant coronary disease was 40-60%. 19 Patients were included in the primary outcome analysis if they had complete data from both CMR and x-ray angiography and had had no interim cardiovascular events. The study was done in accordance with the Declaration of Helsinki and approved by the local research ethics committee. Patients provided informed written consent.
Randomisation and masking
Patients were randomly assigned with respect to the order they received CMR and SPECT by a 24 h automated randomisation service with stratifi ed permuted blocks to ensure that the groups were balanced for age (<65 years and ≥65 years) and sex. The SPECT, CMR, and x-ray angiogram results were analysed in accordance with international criteria, [20] [21] [22] by masked, paired readers with at least 10 years of experience of using their modalities. After x-ray angiography, the SPECT result could be made available on request to enable a decision about re vascularisation (to mask the treating clinician to the result was deemed unethical); however, CMR results were kept masked.
Procedures
By protocol all patients were scheduled for x-ray coronary angiography. Figure 1 shows the CMR protocol. CMR was done at Leeds General Infi rmary with 1·5 Tesla Philips Intera CV scanner (Philips Healthcare, Best, Netherlands). Panel 1 shows the CMR method, with the criteria for positive CMR 19 shown in panel 2. SPECT radionuclide imaging was done at Leeds General Infi rmary with a cardiac gamma camera (MEDISO Cardio-C, Budapest, Hungary). Patients underwent a standard 2-day protocol with ⁹⁹ m Tc tetrofosmin (Myoview) at a dose of 400 MBq adjusted by weight to a maximum 600 MBq per examination (eff ective dose 6-9 mSv) as is advised in guidelines. 24, 25 Stress and rest electrocardiogram gated SPECT images were acquired with an intravenous adenosine protocol identical to that used in CMR (140 μg/kg per min for 4 min) so Figure 1 : Cardiovascular magnetic resonance protocol After a low-resolution survey scan and localisers to defi ne the cardiac long and short axes, intravenous adenosine was administered for 4 min at 140 μg/kg per min, during which fi rst-pass stress perfusion imaging was undertaken with 0·05 mmol/kg dimeglumine gadopentetate. 3D whole heart MR coronary angiography was done after the low resolution coronary survey and free-breathing four chamber cine (used to assess slice coverage and diastolic coronary rest period, respectively). Rest perfusion imaging was undertaken a minimum of 15 min after stress perfusion, with a further injection of 0·05 mmol/kg dimeglumine gadopentetate. A fi nal injection of 0·1 mmol/kg dimeglumine gadopentetate was given after this sequence, bringing the overall gadolinium dose to 0·2 mmol/kg. Resting left ventricular function was then assessed, initially for three slices, planned identically to the perfusion slices, and then for the entire left ventricle with contiguous slices. A modifi ed Look-Locker inversion time scout was done before late gadolinium enhancement imaging in short axis, vertical long axis, and horizontal long axis orientations. Times indicated are approximate and sequence blocks are not drawn to scale.
Panel 1: Cardiovascular magnetic resonance imaging parameters
Balanced steady-state free precession cine imaging 10-12 short axis slices (10 mm thick, no gap) with one slice per breath-hold, 1·6 ms echo time, 3·2 ms repetition time, with a 192 by 192 matrix, 320-400 mm fi eld of view, sensitivity encoding factor 1·7-2·0, and 30-50 phases per cardiac cycle.
Stress and rest perfusion T1-weighted saturation-recovery, single-shot k-space gradient echo pulse sequence, in three 10-mm short axis slices, 1·0 ms echo time, 2·7 ms repetition time, 15° fl ip angle, with a 144 by 144 matrix, 320-460 mm fi eld of view (in-plane spatial resolution 2·2-3·2 mm), sensitivity encoding factor 2, and a single saturation pre-pulse per R-R interval shared over three slices.
3D coronary magnetic resonance angiography
Balanced steady-state free precession pulse sequence with T2-weighted, fat saturation pre-pulses, 100-120 slices 0·9 mm thick, free breathing, with a respiratory navigator, 2·3 ms echo time, 4·6 ms repetition time, with a 304 by 304 matrix, 320-460 mm fi eld of view, sensitivity encoding factor 1·7, and duration of acquisition up to 120 ms per R-R interval (determined by the length of the diastolic rest period).
Late gadolinium enhancement T1-weighted segmented inversion-recovery gradient echo pulse sequence, 10-12 short axis slices with one slice per breath-hold, non-selective 180° pre-pulse, echo time 1·9 ms, repetition time 4·9 ms, fl ip angle 15°, inversion time adjusted individually according to the Look-Locker scan, with a 240 by 240 matrix, and a 320-460 mm fi eld of view dependent on patient size.
that the perfusion techniques were directly comparable. 19 Patients were imaged supine at 64 projections with 3° intervals, every 40 s over a 180° orbit. At each projection eight ECG gated frames per cardiac cycle were acquired (64 by 64 matrix). Transaxial stress and rest slices of 6 mm thickness (spatial resolution of about 10 mm) were reconstructed with a Butterworth scattered backprojection fi lter, cut-off frequency 0·4 Nyquist, and an order of 6. Transaxial slices were re-orientated to the cardiac axes for analysis. Evidence of ischaemia was recorded by visual comparison of rest and stress SPECT perfusion scans (17- 4 [absent] was assigned to each segment). QGS software (version 3.0) was used to calculate end diastolic and end systolic volumes and wall motion scores. As for CMR reporting and according to usual clinical practice, diagnosis was made on the basis of all available SPECT data-ie, rest and stress perfusion, wall motion, and ventricular volumes.
For comparison with CMR, SPECT perfusion summed stress and rest scores (based on a 20-segment model: 0=normal, 1=mildly reduced uptake, 2=moderately reduced uptake, 3=severely reduced uptake, and 4=absent uptake) were calculated with QPS software.
19 All x-ray angiograms were done after CMR and SPECT. Clinically signifi cant coronary heart disease was defi ned as 70% or more stenosis of a fi rst order coronary artery measuring 2 mm or greater in diameter, or left main stem stenosis 50% or more as measured by quantitative coronary angiography with use of QCAPlus software (version 8.11.19) , with a post-stenosis diameter used as the reference vessel diameter in cases of ostial disease.
The primary outcome was diagnostic accuracy of the multiparametric CMR protocol to detect clinically signifi cant coronary heart disease defi ned by x-ray angiography. The main secondary outcome was a comparison of multiparametric CMR (rest and stress perfusion, left ventricular function, coronary magnetic resonance angiography, and late gadolinium enhancement) and SPECT (rest and stress perfusion, left ventricular function) with x-ray angiography as the reference. An additional analysis compared only the equivalent components of the CMR protocol with SPECT.
Statistical analysis
Statistical analyses were done by the Clinical Trials Research Unit, University of Leeds. The sensitivity, specifi city, and positive and negative predictive values were calculated with the Wilson score method. Sensitivity and specifi city were compared with McNemar's test, and predictive values were compared with the generalised score statistic. 26 To compare CMR and SPECT perfusion data for diagnostic performance with receiver operating characteristic analysis, a CMR summed stress score was calculated by adding together all segmental stress perfusion scores. Patients were included in the primary outcome analysis if they had complete data from both CMR and x-ray angiography and had no interim cardiovascular event. Diagnostic performance of CMR and SPECT were compared in patients with assessable results to both tests and x-ray angiography. Statistical analysis was done with SAS software, version 9.2 at a two-sided 5% signifi cance level. If any component was positive, the overall CMR result was judged positive; if all components were negative, the CMR overall result was judged negative. CMR=cardiovascular magnetic resonance. A CMR result based on the components that are assessable by both modalities (ie, perfusion, ventricular function, and scar, but excluding coronary MR angiogram) was generated. This analysis was done to compare only equivalent data from both modalities and to assess the incremental value of CMR coronary imaging.
Role of the funding source
The sponsors provided fi nancial support for the study but had no role in the study design (other than through its external peer review process), data collection, data analysis, data interpretation, or writing of the report. All authors had access to the primary data and have fi nal responsibility for publication.
All randomised patients (N=752)
CMR and x-ray angiography assessable (N=676) CMR, SPECT, and x-ray angiography assessable (CMR before SPECT; N=316) CMR, SPECT, and X-ray angiography assessable (SPECT before CMR; N=312) Figure 2 shows the trial profi le. For the 338 patients excluded after assessment by their cardiologist, the pretest likelihood of coronary heart disease was so low that invasive investigation could not be justifi ed, or invasive angiography was needed so urgently that there could be no delay for non-invasive testing. CMR was not done or completed in 65 (9%) patients, SPECT in 67 (9%), and x-ray angiography in 23 (3% Four patients' results were unavailable for analysis. The table shows baseline characteristics of all patients randomised and of those in the primary analysis; the demographics of all patients randomised, and especially of the primary analysis population, were similar. The overall prevalence of protocol-defi ned signifi cant coronary heart disease was 39% (table) . The median time between CMR or SPECT and x-ray angiography was 21 days (IQR 10-32) and 21 days (12-31), respectively. The median time between CMR and SPECT was 7 days (5-13). Ten patients had 11 serious adverse events, all related to x-ray angiography; eight vascular access site complications (haematoma), one minor neurological event, one ventricular arrhythmia, and one acute event needing percutaneous coronary inter vention.
For the primary outcome measure the sensitivity of CMR was 86·5% (95% CI 81·8-90·1), specifi city 83·4% (79·5-86·7), positive predictive value 77·2% (72·1-81·6), and negative predictive value 90·5% (87·1-93·0). In the secondary outcome measure population, the sensitivity of SPECT was 66·5% (60·4-72·1), specifi city 82·6% (78·5-86·1), positive predictive value 71·4% (65·3-76·9), and negative predictive value 79·1% (74·8-82·8). In this group the comparable values for multiparametric CMR were: sensitivity 86·3% (81·5-90·0), specifi city 83·2% (79·1-86·6), positive predictive value 77·0% (71·7-81·5), and negative predictive value 90·3% (86·7-93·0). The diff erences between the sensitivities and negative predictive values of CMR and SPECT were signifi cantly in favour of CMR (χ² test, p<0·0001 for both), but the specifi cities and positive predictive values were not (p=0·916 and p=0·061, respectively). Figure 3 shows example comparisons of the diff erent tests.
Of the 676 patients who had assessable CMR and x-ray angiography, 598 (88%) had analysable coronary MR angiograms. From the 10 140 (15 for each of the 676 patients) coronary artery segments theoretically available, 5584 (55%) were of analysable quality. When the coronary MR angiogram component was excluded from the overall CMR analysis, CMR sensitivity was 81·6% (76·5-85·8), specifi city 85·9% (82·1-88·9), positive predic tive value 78·9% (73·7-83·3), and negative predictive value 87·8% (84·2-90·6). The overlap in CIs of these measures with those of the primary outcome analysis population, and the spread and heterogeneity across all four components, suggests that although sensitivity might slightly decrease, overall diagnostic accuracy does not diff er if the coronary MR angiogram is excluded.
Compared with SPECT, the diff erences between the sensitivities, positive predictive values, and negative predictive values of the CMR protocol without coronary MR angiography were signifi cant in favour of CMR (p<0·0001, p=0·01, and p<0·0001, respectively), but the specifi cities were not (p=0·224).
For the receiver operating characteristic curve analysis, stress CMR (area under the curve [AUC] 0·89, Late gadolinium-enhanced CMR shows subendocardial inferior infarction (arrow), SPECT was reported as normal (no wall motion abnormality), and the angiogram shows coronary atheroma but no clinically signifi cant stenosis (or occlusion). As per study protocol, CMR in this patient was classifi ed as a false positive, showing the potential limitations of angiography as a reference test for the detection of coronary heart disease. The case also shows that SPECT can miss small subendocardial infarcts. CMR=cardiovascular magnetic resonance. SPECT=single-photon emission computed tomography.
95% CI 0·86-0·91) signifi cantly out-performed SPECT (0·74, 0·70-0·78; p<0·0001; fi gure 4A). Stress perfusion CMR was better than SPECT even when the angiographic cutoff value for a clinically signifi cant stenosis was adjusted to 50% or greater for left main stem and 50% or greater for left anterior descending, left circumfl ex artery, and right coronary artery (AUC for stress CMR 0·84, 95% CI 0·81-0·87 vs AUC for SPECT 0·69, 95% CI 0·65-0·73; p<0·0001; fi gure 4B).
Stress perfusion CMR also performed better than SPECT when single vessel and multivessel coronary artery disease groups were analysed separately (fi gure 4C, 4D, respectively). For single vessel disease the AUC for stress CMR was 0·87 (0·83-0·90) and for SPECT 0·71 (0·66-0·76; p<0·0001). For multivessel disease, the AUC for stress CMR was 0·91 (0·87-0·95) and for SPECT 0·77 (0·72-0·83; p<0·0001).
Discussion
This trial has shown that in a large population with suspected angina pectoris, CMR is an alternative to SPECT for the detection of clinically signifi cant coronary heart disease, with better sensitivity and negative predictive values. Although CMR is already included in international guidelines for the non-invasive detection of coronary heart disease, 28, 29 it does not have the large scale diagnostic accuracy and clinical outcome data of SPECT. The results show that CMR off ers an accurate assessment of single-vessel and multivessel coronary disease, irrespective of the cutoff used for severity of clinically signifi cant angiographic stenosis (≥50% or 70%). This fi nding is important because all non-invasive tests have limitations, such that alternative investigative options are needed. For SPECT, these limitations include the exposure of patients to ionising radiation, limited spatial resolution, and attenuation artifacts, whereas for CMR they include claustrophobia, wide abdominal girth, and the presence of some medical implants.
The coronary heart disease prevalence in CE-MARC (39%) is typical of a hospital outpatient population. Only 11% of patients had previous revascularisation or acute coronary syndrome. This trial population diff ers substantially from that of MR-IMPACT, 18 a contrast dose ranging study in which 241 patients were enrolled after x-ray angiography or when scheduled for angiography after a positive SPECT scan. Disease prevalence in the highly selected MR-IMPACT population was 77%; 31% having had coronary angioplasty and 39% myocardial infarction. Furthermore, in CE-MARC all patients were prospectively scheduled to undergo CMR, SPECT, and x-ray angiography at the time of recruitment, minimising selection bias. To avoid confounding between the order of the tests, the order was randomised, and to avoid confounding between observers and the tests, all tests were done and interpreted in accordance with the strict detailed protocols. 19 CMR and SPECT stress perfusion used identical adenosine infusion protocols and unlike earlier trials, 18 all SPECT studies adopted a unifi ed protocol using 99m Tc tetrofosmin (Myoview) and cardiac gating, as advised in guidelines. 24, 25 CMR and SPECT were reported using international criteria, by two masked independent assessors with at least 10 years experience in their respective modality, [20] [21] [22] and in a manner inkeeping with usual clinical practice.
Importantly, CE-MARC used a multiparametric CMR protocol, unlike the studies in a previous meta-analysis 30 and MR-IMPACT, 18 which used only the perfusion CMR components. The additional clinical information provided by multiparametric CMR is important for individual patient management beyond diagnosis. Although SPECT provides information about ischaemia, infarction, and ventricular function, it provides no detail of coronary artery anatomy. However, omitting coronary artery imaging from the multiparametric CMR protocol did not impair overall diagnostic accuracy, and makes the investigation simpler and quicker. Exclusion of the coronary MR angiography . The sensitivity of CMR in CE-MARC was similar to that in the CMR meta-analysis 30 (86% vs 89%) and to that of a recent prospective study 31 of 136 women (84%). However, direct comparisons should be made with caution (the meta-analysis included many small studies with heterogeneous populations, disease prevalence, and analysis methodologies).
The results of CMR compared with SPECT need to be considered in the context of published SPECT data, which are heterogeneous for population, radioisotope tracer, mode of stress, and protocol. Notably, before CE-MARC, SPECT had never been tested prospectively against coronary angiography in such large numbers and in a patient population of this kind. Previous studies of SPECT show a wide range in sensitivity (63-93%) and specifi city (10-90%) compared with x-ray angiography.
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The sensitivity and specifi city of SPECT in CE-MARC fell within the range of these other studies. A UK National Institute for Health and Clinical Excellence technology appraisal 2 reported that "considerable uncertainty remains over the true values for sensitivity and specifi city of SPECT. In particular, trials that assessed these values were subject to referral bias, in that only SPECT-positive cases were referred for coronary angiography, which was assumed to be the gold standard". CE-MARC prospectively recruited patients before any imaging procedure and all patients had x-ray angiography, irrespective of clinical intention. Although this design might have increased the number of false negatives for both SPECT and CMR it might be more representative of the real sensitivity of both. The high specifi cities reported in CE-MARC for both modalities might result from the use of ECG gating during SPECT and an awareness of dark banding artifacts during CMR analysis-a common source of false-positives in CMR perfusion studies. The results of CE-MARC and MR-IMPACT 18 are similar (AUC by ROC analysis 0·89 and 0·86 [n=42], respectively). These concordant results using diff erent CMR stress perfusion acquisition protocols show the inherent accuracy of this technique. Although we have not specifi cally sought to address why CMR has superior accuracy to SPECT, it might relate partly to its higher spatial resolution (2·2-3·2 mm for CMR vs approximately 10 mm in-plane for SPECT).
Our study has some limitations. Most patients were white northern Europeans who had not had previous coronary artery bypass surgery; results might diff er in other populations. Also, CE-MARC was a single-centre study in which CMR and SPECT are done in high volumes. Extrapolation to low volume centres should be made with caution. Importantly, a single site and unifi ed pharmacological stress protocol ensured consistency in CMR and SPECT and improved direct comparison.
CE-MARC compared two functional tests (CMR and SPECT) with an anatomical test (angiography), itself an imperfect reference standard. Thus, false-negative results could occur if lesions not causing ischaemia (as assessed by CMR or SPECT) were judged clinically signifi cant on the basis of angiographic stenosis severity. Quantitative coronary angiography, which is considered better than visual estimation, was used, but it is still a crude binary measure that fails to account for diff use disease, length of diseased segment, serial stenoses, and microvascular disease. Invasive measurement of fractional fl ow reserve is now the reference standard for the measurement of haemodynamic signifi cance of a coronary artery stenosis and should be used in future studies. Indeed, results from the FAME trial 32 showed a wide discrepancy between angiographic stenosis classifi cation and fractional fl ow re serve measurements.
CE-MARC is the largest, prospective, real world assessment of CMR. The fi ndings of CE-MARC support the wider adoption of CMR for the diagnosis and manage ment of stable coron ary heart disease patients, in view of the growing concern of the cancer risk associated with medicalsource ionising radiation.
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Study investigators
Systematic review
We searched PubMed for original papers in English, with no date restriction, with the terms "cardiovascular magnetic resonance", "stress perfusion imaging", "coronary heart disease", "ischaemic heart disease", and "single photon emission computed tomography". There are no large scale diagnostic accuracy studies of a multiparametric cardiovascular magnetic resonance (CMR) protocol for the detection of coronary heart disease. A meta-analysis 30 has shown that stress perfusion CMR is highly sensitive but only moderately specifi c for the detection of coronary heart disease. A small subgroup analysis of the MR-IMPACT trial 18 suggests that stress perfusion CMR and single-photon emission computed tomography (SPECT) have much the same diagnostic accuracy.
Interpretation CE-MARC is the fi rst large-scale trial of a multiparametric CMR protocol for the diagnosis of stable coronary heart disease. CMR had better sensitivity and negative predictive values than SPECT for coronary heart disease diagnosis, with much the same specifi city. These fi ndings support the wider adoption of CMR for coronary heart disease diagnosis and its inclusion in evidence-based clinical management guidelines.
